Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 4, 1998, Pages 421-425

  Mouzas, I A ^a,c   Papavassiliou, E ^a,b   Koutroubakis, ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b NIMTS HOSPITAL   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Chemoprevention; Colorectal cancer; Crohn's disease; Folate; Inflammatory bowel disease

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CARBENOXOLONE; EFLORNITHINE; ELLAGIC ACID; FISH OIL; FOLIC ACID; MINERAL; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; OMEGA 3 FATTY ACID; ORGANOPHOSPHORUS COMPOUND; RETINOL; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RISK; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CROHN DISEASE; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE DURATION; DRUG INHIBITION; DRUG MECHANISM; DRUG RESEARCH; ENTERITIS; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; NONHUMAN; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; FOLIC ACID; HUMANS; INFLAMMATORY BOWEL DISEASES; RISK FACTORS;

EID: 0031715252     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Mörsern BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
2. Ridell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Human Pathol 1983;14:931-68.
3. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder K.W, Welling DR, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.
4. Lofberg R, Brostrom O, Karlen P, Tribukat B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis. A 15-year follow-study. Gastroenterology 1990;99:1021-31.
5. Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
6. Connel WR, Lennard-Jones JE, Williams CB, Talbot 1C, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopie surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
7. Dixon MF, Brown LJR, Gilmour HM, Price AB, Smeeton NC, Talbot 1C, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-97.
8. Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopie surveillance program of patients with ulcerative colitis. Gastroenterology 1995;108:1361-70.
9. Axon AT. Cancer surveillance in ulcerative colitis. A time for reappraisal. Editorial. Gut 1994;35:587-9.
10. Hanauer SB, Present DH, Murphy LK. Challenges in IBD research: the clinical research agenda. Inflammatory Bowel Diseases 1996;2:189-99.
11. Devroede GJ, Taylor WF, Sauer \VG, Jackman RJ, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Eng J Med 1971:285:17-21.
12. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JAH, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982:23:490-7.
13. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population based study. N Eng J Med 1990; 1228-33.
14. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen. Gut 1985:26:158-63.
15. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Sur-vival and causes of death in patients with inflammatory bowel disease: a population based study. Gastroenterology 1992;103:954-60.
16. Warren S, Sommers SC. Cicatrizing enteritis (regional ileitis) as a pathologic entity: analysis of one hundred and twenty cases. AmJPathol 1948;24:475-501.
17. Weedon DD, Shorter RG, Ilstrup DM. Crohn's disease and cancer. N Eng J Med 1973;289:1099-103.
18. Ekbom A, Helminck C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonie involvement. Lancet 1990;336:357-9.
19. Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981;48:2742-5.
20. Gillen CD, Prior P.Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-2.
21. Krishnan K, Brenner DE. Chemoprevention of colorectal cancer. Gastroenterol Clin North Am 1996:25:821-58.
22. Sandler RS. Chemoprevention colonie neoplasia. AGA Postgraduate Course 1995:165-75.
23. Muscat JE, Stellman SD, Wynder EL. Non-steroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994:74:1847-54.
24. Thun MJ, Nambodiri MM, Health CWJ. Aspirin use and reduced risk of fatal colon cancer. N Eng J Med 1991:325:1593-6.
25. DuBois RN, Giardiello FM, Smalley WE. Non-steroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am 1996;25:773-91.
26. Vogel VG, McPherson RS. Dietary epidemiology of colon cancer. Hematol Oncol Clin North Am 1989;3:35-63.
27. Sandier RS. Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am 1996;25:17-35.
28. Clark LC, Xixson LJ, Combs GFJ, Reid ME, Turnbull BW, Sampliner RE. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993:2:41-6.
29. Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp prevention study group. N Eng J Med 1994:331:141-7.
30. Kampman E, Giovannucci E, van't Veer P, Rimm E, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, dairy foods and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 1994;139:16-29.
31. Howe GR, Benito E, Castelleto R, Cornée J, Esteve J, Gal-lagher RP, et al. Dietary intake of fibre and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-96.
32. Sumiyoshi H, Wargovich MJ. Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 1990;50-5084-7.
33. Rao CV, Tokomo K, Kelloff G, Reddy BS. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis 1991;12:1051-5.
34. Rigas B, Tsioulias GJ, Allan C, Walli RK, Brasitus TA. The effects of bile acid and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. Immunology 1994;83:319-23.
35. Editorial. Primary chemoprevention strategies for colorectal cancer. Ursodeoxycholic acid and other agents. Gastroenterology 1995; 109:2036-8.
36. Singh J, Kelloff G, Reddy BS. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Cancer Epidemiol Biomarkers Prev 1992;1:405-11.
37. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875-84.. .
38. Rosenberg EH, Mason JB. Folate, dysplasia and cancer. Editorial. Gastroenterology 1989;97:502-5.
39. Mason JB, Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology 1996;10:1727-36.
40. Seihub J, Dhar GH, Rosenberg IH. Inhibition of folate enzymes by sulfasalazinc. J Clin Invest 1978;61:221-4.
41. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989;97:255-9.
42. Lashner BA. Red blood cell folate is associated with the development of dysplasia in ulcerative colitis. J Cancer Res Clin Oncol 1993;! 19:549-54.
43. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A. The effect of folic acid supplementation on the risk for cancer and dysplasia in ulcerative colitis. Gastroenterology 1997; 112:29-32.
44. Biasco G, Zannoni U, Paganelli GM, Santucci R, Gionchetti P, Givolta TI. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 1997 ;6:469-71.